Related Experiment Video
Updated: Jul 25, 2025

10:45
A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
Published on: January 6, 2023
2.3K
Preclinical Mouse Model of Silicosis
Maggie Lam1,2, Ashley Mansell1,2, Michelle D Tate3,4
1Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Methods in Molecular Biology (Clifton, N.J.)
|June 24, 2023
Summary
This study details a novel intranasal mouse model for silicosis, an occupational lung disease. This model effectively mimics human disease progression, aiding research into treatments for silica-induced fibrosis.
Area of Science:
- Occupational Medicine
- Pulmonary Pathology
- Toxicology
Background:
- Silicosis is an irreversible occupational lung disease from crystalline silica inhalation.
- Current preclinical models often use intratracheal administration, differing from human inhalation exposure.
- Understanding silica's cellular mechanisms is crucial for developing treatments.
Purpose of the Study:
- To describe a mouse model of silicosis using intranasal silica instillation.
- To establish a method that better mimics human inhalation exposure.
- To provide a tool for studying chronic fibrotic lung diseases.
Main Methods:
- Intranasal instillation of silica particles in mice.
- Histological analysis of lung tissue using hematoxylin and eosin and Masson's trichrome staining.
- Assessment of silica distribution, inflammation, tissue damage, and fibrosis.
Main Results:
- The intranasal model replicates key pathological features of human silicosis.
- Histological analysis revealed silica particle distribution, inflammation, and progressive fibrosis.
- The model allows for detailed examination of disease progression and cellular responses.
Conclusions:
- Intranasal silica instillation provides a clinically relevant preclinical model for silicosis.
- This model facilitates research into the pathogenesis of silica-induced lung disease.
- The approach is adaptable for studying other particle-induced fibrotic lung conditions.

